This list is an analysis based on recent market events. It's not an investment recommendation.
About
Isofol Medical AB (publ) operates as a clinical stage biotech company. The company develops arfolitixorin, which is in phase Ib/II clinical trial for the treatment of metastatic colorectal cancer. Isofol Medical AB (publ) was incorporated in 2008 and is based in Gothenburg, Sweden.
The current price of 5IU.F is €0.05 EUR — it has decreased by -1.27% in the past 24 hours. Watch Isofol Medical AB stock price performance more closely on the chart.
What is Isofol Medical AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Isofol Medical AB stocks are traded under the ticker 5IU.F.
Is Isofol Medical AB stock price growing?▼
5IU.F stock has risen by +7.89% compared to the previous week, the month change is a -1.69% fall, over the last year Isofol Medical AB has showed a -69.57% decrease.
What is Isofol Medical AB market cap?▼
Today Isofol Medical AB has the market capitalization of 13.07M
When is the next Isofol Medical AB earnings date?▼
Isofol Medical AB is going to release the next earnings report on May 19, 2026.
What is Isofol Medical AB revenue for the last year?▼
Isofol Medical AB revenue for the last year amounts to 0 EUR.
What is Isofol Medical AB net income for the last year?▼
5IU.F net income for the last year is -13.77M EUR.
How many employees does Isofol Medical AB have?▼
As of April 07, 2026, the company has 6 employees.
In which sector is Isofol Medical AB located?▼
Isofol Medical AB operates in the Health Care sector.
When did Isofol Medical AB complete a stock split?▼
Isofol Medical AB has not had any recent stock splits.
Where is Isofol Medical AB headquartered?▼
Isofol Medical AB is headquartered in Gothenburg, DE.